Log In
Print
BCIQ
Print
Print this Print this
 

hTERT DNA cancer vaccine (INO-1400)

  Manage Alerts
Collapse Summary General Information
Company Inovio Pharmaceuticals Inc.
DescriptionDNA cancer vaccine targeting human telomerase reverse transcriptase (hTERT) delivered using Inovio's Cellectra intradermal electroporation device
Molecular Target Telomerase reverse transcriptase (TERT)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today